Jonathan G Drachman's Net Worth
Jonathan G Drachman's net worth is estimated to be at least $1,757,930.75 as of 11/22/2024. CoreStreet's estimation of Jonathan G Drachman's net worth is based on their sale of stock and current holding of stock.
Jonathan G Drachman is CEO at Neoleukin Therapeutics. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 100,000 units of NLTX stock on 08/24/2021. Their biggest sale was on 06/22/2017 when they sold 10,000 units of Seagen Inc stock for $640,100.00. They typically trade 1 times per year.
Total value of insider buys:
- $990,200.00
Total value of insider sells:
- $767,730.75
Most recent insider trade:
- Aug. 24, 2021
Jonathan G Drachman's Insider Trading History
| Neoleukin Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 24, 2021 | CEO | 100,000 | $6.11 | Buy | $611,000.00 |
June 3, 2021 | CEO | 40,000 | $9.48 | Buy | $379,200.00 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 22, 2017 | CMO | 10,000 | $64.01 | Sell | $640,100.00 |
Sept. 22, 2016 | CMO | 2,249 | $56.75 | Sell | $127,630.75 |